| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
ADAM28 overexpression regulated via the PI3K/Akt pathway is associated with relapse in de novo adult B-cell acute lymphoblastic leukemia
|
Zhang, Xiao-Hui
|
|
2015
|
39 |
11 |
p. 1229-1238
10 p.
|
artikel
|
| 2 |
Amerindian genetic ancestry and INDEL polymorphisms associated with susceptibility of childhood B-cell Leukemia in an admixed population from the Brazilian Amazon
|
Carvalho, Darlen C.
|
|
2015
|
39 |
11 |
p. 1239-1245
7 p.
|
artikel
|
| 3 |
A molecular risk score integrating BAALC, ERG and WT1 expression levels for risk stratification in acute promyelocytic leukemia
|
Hecht, Anna
|
|
2015
|
39 |
11 |
p. 1172-1177
6 p.
|
artikel
|
| 4 |
A phase II exercise randomized controlled trial for patients with acute myeloid leukemia undergoing induction chemotherapy
|
Alibhai, S.M.H.
|
|
2015
|
39 |
11 |
p. 1178-1186
9 p.
|
artikel
|
| 5 |
Azacitidine in the treatment of older patients affected by acute myeloid leukemia: A report by the Rete Ematologica Pugliese (REP)
|
Delia, Mario
|
|
2015
|
39 |
11 |
p. 1166-1171
6 p.
|
artikel
|
| 6 |
BCL2 gene polymorphisms and splicing variants in chronic myeloid leukemia
|
Guillem, Vicent
|
|
2015
|
39 |
11 |
p. 1278-1284
7 p.
|
artikel
|
| 7 |
Beta-2 microglobulin is a strong prognostic factor in patients with DLBCL receiving R-CHOP therapy
|
Miyashita, Kazuho
|
|
2015
|
39 |
11 |
p. 1187-1191
5 p.
|
artikel
|
| 8 |
BRAFV600E induces ABCB1/P-glycoprotein expression and drug resistance in B-cells via AP-1 activation
|
Tsai, Yo-Ting
|
|
2015
|
39 |
11 |
p. 1270-1277
8 p.
|
artikel
|
| 9 |
Comparison of outcomes of idarubicin intensified TBI–CY and traditional TBI–CY conditioning regimen for high-risk acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation: A single center experience
|
Wu, Qiuling
|
|
2015
|
39 |
11 |
p. 1192-1200
9 p.
|
artikel
|
| 10 |
Comparison of three prognostic scoring systems in a series of 146 cases of chronic myelomonocytic leukemia (CMML): MD Anderson prognostic score (MDAPS), CMML-specific prognostic scoring system (CPSS) and Mayo prognostic model. A detailed review of prognostic factors in CMML
|
Calvo, Xavier
|
|
2015
|
39 |
11 |
p. 1146-1153
8 p.
|
artikel
|
| 11 |
Comparison of TP53 mutations screening by functional assay of separated allele in yeast and next-generation sequencing in myelodysplastic syndromes
|
Bally, Cécile
|
|
2015
|
39 |
11 |
p. 1214-1219
6 p.
|
artikel
|
| 12 |
Cytotoxic activity of T lymphocytes is induced upon stimulation with IL-3 plus GM-CSF in animal leukemia model
|
Singha, Ashish Kumar
|
|
2015
|
39 |
11 |
p. 1255-1262
8 p.
|
artikel
|
| 13 |
Disruption of pre-B-cell receptor signaling jams the WNT/β-catenin pathway and induces cell death in B-cell acute lymphoblastic leukemia cell lines
|
Saba, Nakhle S.
|
|
2015
|
39 |
11 |
p. 1220-1228
9 p.
|
artikel
|
| 14 |
Editorial board and publication information
|
|
|
2015
|
39 |
11 |
p. IFC-
1 p.
|
artikel
|
| 15 |
Efficacy of cytarabine, aclarubicin and granulocyte colony-stimulating factor (CAG) regimen compared to FLAG regimen for adult patients with relapsed/refractory Philadelphia chromosome-negative acute lymphoblastic leukemia
|
Li, Xiaoli
|
|
2015
|
39 |
11 |
p. 1201-1206
6 p.
|
artikel
|
| 16 |
Flow cytometry in immunoglobulin light chain amyloidosis: Short review
|
Filipova, Jana
|
|
2015
|
39 |
11 |
p. 1131-1136
6 p.
|
artikel
|
| 17 |
Identification of ILK as a novel therapeutic target for acute and chronic myeloid leukemia
|
de la Puente, Pilar
|
|
2015
|
39 |
11 |
p. 1299-1308
10 p.
|
artikel
|
| 18 |
Mcl-1 downregulation leads to the heightened sensitivity exhibited by BCR-ABL positive ALL to induction of energy and ER-stress
|
Leclerc, Guy J.
|
|
2015
|
39 |
11 |
p. 1246-1254
9 p.
|
artikel
|
| 19 |
Mutational analysis of telomere complex genes in Indian population with acquired aplastic anemia
|
Singh, Ishwar
|
|
2015
|
39 |
11 |
p. 1263-1269
7 p.
|
artikel
|
| 20 |
Prognostic impact of combined NPM1+/FLT3− genotype in patients with acute myeloid leukemia with intermediate risk cytogenetics stratified by age and treatment modalities
|
Hefazi, Mehrdad
|
|
2015
|
39 |
11 |
p. 1207-1213
7 p.
|
artikel
|
| 21 |
Ruxolitinib treatment for myelofibrosis: Efficacy and tolerability in routine practice
|
Ellis, Martin H.
|
|
2015
|
39 |
11 |
p. 1154-1158
5 p.
|
artikel
|
| 22 |
Smoking as a contributing factor for development of polycythemia vera and related neoplasms
|
Hasselbalch, Hans Carl
|
|
2015
|
39 |
11 |
p. 1137-1145
9 p.
|
artikel
|
| 23 |
STAT transcript levels in childhood acute lymphoblastic leukemia: STAT1 and STAT3 transcript correlations
|
Adamaki, Maria
|
|
2015
|
39 |
11 |
p. 1285-1291
7 p.
|
artikel
|
| 24 |
Telomere dynamics in patients with del (5q) MDS before and under treatment with lenalidomide
|
Beier, Fabian
|
|
2015
|
39 |
11 |
p. 1292-1298
7 p.
|
artikel
|
| 25 |
The presence of low-count chronic lymphocytic leukemia-like monoclonal B lymphocytosis in patients with Ph-myeloproliferative neoplasms: A random event or a shared causal pathobiology?
|
Diamantidis, Michael D.
|
|
2015
|
39 |
11 |
p. 1129-1130
2 p.
|
artikel
|
| 26 |
Three-fold higher frequency of circulating chronic lymphocytic leukemia-like B-cell clones in patients with Ph-Myeloproliferative neoplasms
|
Miltiades, Paraskevi
|
|
2015
|
39 |
11 |
p. 1159-1165
7 p.
|
artikel
|
Tijdschrift beschrijving